Trazodone induced galactorrhea: a case report.

Abstract

Trazodone is a heterocyclic antidepressant that exerts its effect via the inhibition of selective serotonin reuptake and the antagonism of 5-HT2A and 5-HT2C receptors. Antidepressant-induced galactorrhea and increases in prolactin levels have rarely been reported. Trazodone can potentiate the serotonergic activity of citalopram. To our knowledge, no cases of galactorrhea associated with use of trazodone have been reported to date. This report describes a unique case of the development of galactorrhea following the addition of trazodone (100 mg/day, 2 weeks) to the treatment of a patient who was receiving citalopram (40 mg/day, 6 weeks) therapy for a diagnosis of depressive disorder, which improved upon the discontinuation of trazodone.

• Authors: Filiz Civil Arslan, Emel Korkmaz Uysal, Evrim Ozkorumak, Ahmet Tiryaki
• Journal: General hospital psychiatry (Gen Hosp Psychiatry) 2015 Jul-Aug Vol. 37 Issue 4 Pg. 373.e1-2 ISSN: 1873-7714 [Electronic] United States
• PMID: 25920951 (Publication Type: Case Reports, Journal Article)
• Copyright: Copyright © 2015 Elsevier Inc. All rights reserved.

Chemical References

• Serotonin Uptake Inhibitors
• Citalopram
• Trazodone

Topics

• Citalopram (therapeutic use)
• Depressive Disorder (drug therapy)
• Drug Therapy, Combination
• Female
• Galactorrhea (chemically induced)
• Humans
• Hyperprolactinemia (chemically induced)
• Selective Serotonin Reuptake Inhibitors (adverse effects, therapeutic use)
• Trazodone (adverse effects)
• Young Adult